整合素β4在肝細胞癌侵襲轉(zhuǎn)移中的作用機制研究
[Abstract]:Objective: to compare the expression of integrin 尾 4 (ITGB4) in human hepatocellular carcinoma (HCC) (Hepatocellular carcinoma, HCC) tissues and corresponding paracancerous tissues, and to compare the expression of integrin 尾 4 in different hepatocellular carcinoma cell lines. To analyze the relationship between integrin p4 and clinicopathological features of hepatocellular carcinoma (HCC) and to explore the role of integrin p4 in the invasion and metastasis of HCC. Methods: 68 cases of hepatocellular carcinoma were selected from the liver surgery center of Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology. Seven hepatocellular carcinoma cell lines with different metastatic ability were selected and used western-blot,. Immunohistochemical (immunohistochemistry, IHC) and other methods were used to detect the expression of integrin 尾 4 between cancer and paracancerous tissues as well as between different cell lines. The effect of integrin 尾 4 expression on the clinicopathological characteristics of HCC was analyzed by statistical method. Results: integrin p4 was highly expressed in human hepatocellular carcinoma tissues, but low expression or no expression in paracancerous tissues. The high expression of integrin 尾 4 in cancer tissues was positively correlated with local invasion and low differentiation. Integrin 尾 4 was highly expressed in hepatocellular carcinoma cell line (HLF, MHCC97L, MHCC97H, HCCLM3) with high invasion and metastasis, but low expression or no expression in low invasion and metastasis hepatoma cell line (Hep3B,HepG2,Huh7). Conclusion: the high expression of integrin 尾 4 in HCC and HCC cell lines with high metastatic ability can promote the invasion and metastasis of HCC. Aim: to study the effect of integrin 尾 4 (ITGB4) on the Anchorage independent growth of (anchorage independence) in hepatocellular carcinoma cells and the mechanism of its regulation. Methods: hepatocellular carcinoma cell lines HCCLM3 and HLF, with high expression of integrin 尾 4 were selected to knock down the expression of integrin 尾 4 by RNA interference (RNAi) technique. The modified cell lines were used to form (soft agarose colony formation), by soft Agar cloning. The effect of integrin 尾 4 on Anchor-independent growth of Hepatocellular carcinoma was studied by (anoikis assay) analysis of out-of-nest apoptosis. Western blot, immunoprecipitation (Co-Immunoprecipitation, Co-IP) and cellular immunofluorescence were used to study the effects of integrin 尾 4-regulated cell signaling pathway on anchor-independent growth of HCC cells. Results: integrin 尾 4 enhanced anchor independent growth of HCC cells, and integrin 尾 4 promoted anchor independent growth through activation of AKT/PKB signaling pathway. Integrin 尾 4 binds to epidermal growth factor receptor (epidermal growth factor receptor, EGFR) in a ligand-independent manner to promote anchor-independent growth, and the ITGB4-EGFR complex activates the AKT signaling pathway through FAK (focal adhesion kinase) instead of Src. Conclusion: ITGB4-EGFR complex can promote the growth of HCC cells by activating FAK-AKT signaling pathway. Objective: to study the effect of integrin 尾 4 on the growth and lung metastasis of hepatocellular carcinoma (HCC) in vivo. Methods: the effect of integrin 尾 4 on the growth of hepatocellular carcinoma (HCC) in vivo and the effect of integrin p4 on the lung metastasis of HCC were studied by subcutaneously tumorigenic model of nude mice and the model of lung metastasis of HCC cells injected intravenously. Results: ITGB4-EGFR-activated FAK-AKT pathway could promote the growth of HCC in vivo, and ITGB4-EGFR-activated FAK-AKT pathway could promote lung metastasis of HCC. Conclusion: ITGB4-EGFR-FAK-AKT signaling pathway promotes the growth and lung metastasis of HCC in vivo.
【學位授予單位】:華中科技大學
【學位級別】:博士
【學位授予年份】:2016
【分類號】:R735.7
【相似文獻】
相關期刊論文 前10條
1 李艷萍,曾文潔,張志華;整合素與生殖[J];生殖與避孕;2000年01期
2 倪兆慧,張慶怡;整合素家族與腎小球系膜研究進展[J];國外醫(yī)學.泌尿系統(tǒng)分冊;1997年06期
3 熊濤;屈藝;母得志;;整合素連接激酶與整合素[J];實用兒科臨床雜志;2009年23期
4 陸競艷;韋敏怡;;TM4SF家族及其與整合素的相關研究[J];醫(yī)學綜述;2007年05期
5 解元;王樂民;;整合素在人體機能中的作用[J];同濟大學學報(醫(yī)學版);2010年01期
6 穆昱;陳艷;王熙才;;整合素與肺癌[J];腫瘤防治研究;2011年03期
7 王琰琰;張爽;;整合素家族在卵巢癌中的研究進展[J];社區(qū)醫(yī)學雜志;2006年21期
8 柯吳堅;車雅敏;;整合素與人乳頭瘤病毒感染[J];重慶醫(yī)學;2010年18期
9 劉永全;整合素與信號轉(zhuǎn)導[J];國外醫(yī)學(免疫學分冊);2000年01期
10 李娜;張賀龍;;整合素家族與腫瘤骨轉(zhuǎn)移相關性研究進展[J];現(xiàn)代腫瘤醫(yī)學;2011年03期
相關博士學位論文 前4條
1 李菁菁;骨橋蛋白與整合素相互作用調(diào)節(jié)血管平滑肌細胞黏附和遷移的分子機制[D];河北醫(yī)科大學;2006年
2 蘭心剛;肺癌組織中KAI1/CD82和整合素α5表達的臨床意義及二者相關性的研究[D];中國醫(yī)科大學;2003年
3 曹永寬;人AWP1與整合素αV胞內(nèi)功能域的相互作用及其生物學功能的初步鑒定[D];第三軍醫(yī)大學;2004年
4 王紹娟;整合素αvβ3在胚胎發(fā)育中分子生物學及免疫學作用機制研究[D];武漢大學;2014年
相關碩士學位論文 前3條
1 曾海山;趨化因子作用下整合素活化的力學調(diào)控機制[D];華南理工大學;2015年
2 林斯妮;β1整合素的表達純化及在篩查幽門螺桿菌與之結合蛋白中的應用[D];福建醫(yī)科大學;2015年
3 李金麗;整合素α_4β_7高親和性人源單克隆抗體的篩選和功能檢測[D];河南師范大學;2014年
,本文編號:2472541
本文鏈接:http://sikaile.net/yixuelunwen/zlx/2472541.html